Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,633 | 47 | 97.5% |
| Education | $42.64 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $389.86 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $321.86 | 8 | $0 (2024) |
| AbbVie, Inc. | $244.34 | 4 | $0 (2019) |
| Medtronic, Inc. | $119.05 | 1 | $0 (2024) |
| AngioDynamics, Inc. | $95.27 | 1 | $0 (2023) |
| BIOTRONIK INC. | $76.93 | 1 | $0 (2023) |
| Lilly USA, LLC | $76.65 | 5 | $0 (2023) |
| Abbott Laboratories | $66.48 | 3 | $0 (2024) |
| Averitas Pharma Inc. | $31.78 | 1 | $0 (2024) |
| Vertos Medical, Inc. | $30.45 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.91 | 11 | Medtronic, Inc. ($119.05) |
| 2023 | $545.24 | 19 | AstraZeneca Pharmaceuticals LP ($142.65) |
| 2022 | $475.75 | 10 | Novo Nordisk Inc ($274.42) |
| 2019 | $324.11 | 9 | AbbVie, Inc. ($244.34) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 12/07/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $119.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/21/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | DJO, LLC | CMF (Device) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Osteogenesis Stimulators | ||||||
| 06/10/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Pain Management | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.38 | General |
| 08/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Orthopedics | ||||||
| 06/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Oncology | ||||||
| 06/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 06/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 05/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 05/08/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Bone Health | ||||||
| 04/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $117.17 | General |
| Category: Respiratory | ||||||
| 04/05/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 03/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 83 | $29,826 | $4,878 |
| 2022 | 1 | 12 | 24 | $442.80 | $57.44 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 34 | $17,353 | $2,850 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $11,901 | $1,929 | 16.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 31 | $571.95 | $99.40 | 17.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 12 | 24 | $442.80 | $57.44 | 13.0% |
About Dr. Michael Brady, D.O
Dr. Michael Brady, D.O is a Family Medicine healthcare provider based in Wittmann, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1275853715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Brady, D.O has received a total of $1,676 in payments from pharmaceutical and medical device companies, with $330.91 received in 2024. These payments were reported across 49 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,633).
As a Medicare-enrolled provider, Brady has provided services to 63 Medicare beneficiaries, totaling 107 services with total Medicare billing of $4,935. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wittmann, AZ
- Active Since 06/07/2010
- Last Updated 01/16/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275853715
Products in Payments
- FARXIGA (Drug) $204.69
- Ozempic (Drug) $165.03
- Saxenda (Drug) $122.24
- INCEPTIV (Device) $119.05
- BREZTRI (Drug) $117.17
- AURYON LASER SYSTEM 100-120 VAC (Device) $95.27
- Pulsar-18 T3 (Device) $76.93
- Rybelsus (Drug) $68.55
- Mavyret (Drug) $54.22
- MOUNJARO (Drug) $46.85
- QUTENZA (Drug) $31.78
- mild Device Kit (Device) $30.45
- JARDIANCE (Drug) $29.80
- Cologuard Collection Kit (Device) $27.73
- CMF (Device) $26.39
- JOT DX (Device) $25.33
- Proclaim Family of SCS IPGs (Device) $20.83
- AVEIR (Device) $20.32
- MACI (Biological) $19.05
- Nalu Neurostimulation System (Device) $18.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.